Fulgent Genetics (FLGT) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $72.4 million.
- Fulgent Genetics' Total Current Liabilities fell 211.38% to $72.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.4 million, marking a year-over-year decrease of 211.38%. This contributed to the annual value of $72.9 million for FY2024, which is 16.3% down from last year.
- Fulgent Genetics' Total Current Liabilities amounted to $72.4 million in Q3 2025, which was down 211.38% from $71.3 million recorded in Q2 2025.
- Over the past 5 years, Fulgent Genetics' Total Current Liabilities peaked at $196.5 million during Q1 2021, and registered a low of $61.4 million during Q3 2023.
- Over the past 5 years, Fulgent Genetics' median Total Current Liabilities value was $75.9 million (recorded in 2024), while the average stood at $95.8 million.
- As far as peak fluctuations go, Fulgent Genetics' Total Current Liabilities surged by 328261.62% in 2021, and later plummeted by 4917.23% in 2023.
- Quarter analysis of 5 years shows Fulgent Genetics' Total Current Liabilities stood at $105.3 million in 2021, then fell by 16.34% to $88.1 million in 2022, then decreased by 17.13% to $73.0 million in 2023, then decreased by 0.16% to $72.9 million in 2024, then dropped by 0.65% to $72.4 million in 2025.
- Its Total Current Liabilities stands at $72.4 million for Q3 2025, versus $71.3 million for Q2 2025 and $65.9 million for Q1 2025.